Saudi Gazette reportRIYADH — The Saudi Food and Drug Authority (SFDA) has officially approved the registration of lecanemab (Leqembi) for the treatment of patients with early-stage Alzheimer’s disease,Saudi Gazette reportRIYADH — The Saudi Food and Drug Authority (SFDA) has officially approved the registration of lecanemab (Leqembi) for the treatment of patients with early-stage Alzheimer’s disease,
Saudi Arabia approves first Alzheimer’s treatment with lecanemab for early-stage patients
